scholarly journals DANA PIHAK KETIGA PADA PERBANKAN SYARIAH DI INDONESIA

2021 ◽  
Vol 5 (2) ◽  
pp. 111-121
Author(s):  
Budi Gautama Siregar
Keyword(s):  

Penelitian ini bertujuan untuk menganalisis pengaruh equivalent rate, inflasi dan likuiditas terhadap dana pihak ketiga pada perbankan syariah di Indonesia periode 2015-2019. Populasi penelitian adalah laporan keuangan perbankan syariah dengan periode bulanan dari tahun 2015-2019. Dengan teknik sampling jenuh ditentukan jumlah sampel sebanyak 60 bulan. Teknik pengumpulan data yang digunakan adalah studi dokumentasi yaitu laporan keuangan perbankan syariah di Indonesia yang dipublikasikan oleh Otoritas Jasa Keuangan dan Bank Indonesia. Pengolahan data dilakukan dengan analisis regresi berganda dengan bantuan aplikasi SPSS. Temuan penelitian yaitu equivalent rate berpengaruh terhadap dana pihak ketiga, inflasi tidak berpengaruh terhadap dana pihak ketiga dan  Likuiditas berpengaruh terhadap dana pihak ketiga

2020 ◽  
Vol 3 (4) ◽  
pp. e000195
Author(s):  
Meagan E Wiebe ◽  
Anna C Shawyer

ObjectiveCentralization of medical services in Canada has resulted in patients travelling long distances for healthcare, which may compromise their health. We hypothesized that children living farther from a children’s hospital were offered and attended fewer follow-up appointments.MethodsWe reviewed children less than 17 years of age referred to the general surgery clinic at a tertiary children’s hospital during a 2-year period who underwent surgery. Descriptive statistics were performed.ResultsWe identified 723 patients. The majority were male (61%) with a median age of 7 years (range 18 days to16 years) and were from the major urban center (MUC) (56.3%). The median distance travelled to hospital for MUC patients was 8.9 km (range 0.9–22 km) vs 119.5 km (range 20.3–1950 km) for non-MUC patients. MUC children were offered more follow-up appointments (72.7% vs 60.8%, p<0.05). No significant differences existed in follow-up attendance rates (MUC 88.5% vs non-MUC 89.1%, p=0.84) or postoperative complications (9.8% vs 9.2%, p=0.78). There were no deaths.ConclusionsPatients living farther from a hospital were offered fewer follow-up appointments, but attended an equivalent rate of follow-ups when offered one. Telemedicine and remote follow-up are underused approaches that can permit follow-up appointments while reducing associated travel time and expenses.


2021 ◽  
pp. 1-9
Author(s):  
Clint W. Beiermann ◽  
Cody F. Creech ◽  
Stevan Z. Knezevic ◽  
Amit J. Jhala ◽  
Robert Harveson ◽  
...  

Abstract A prepackaged mixture of desmedipham + phenmedipham was previously labeled for control of Amaranthus spp. in sugarbeet. Currently, there are no effective POST herbicide options to control glyphosate-resistant Palmer amaranth in sugarbeet. Sugarbeet growers are interested in using desmedipham + phenmedipham to control escaped Palmer amaranth. In 2019, a greenhouse experiment was initiated near Scottsbluff, NE, to determine the selectivity of desmedipham and phenmedipham between Palmer amaranth and sugarbeet. Three populations of Palmer amaranth and four sugarbeet hybrids were evaluated. Herbicide treatments consisted of desmedipham and phenmedipham applied singly or as mixtures at an equivalent rate. Herbicides were applied when Palmer amaranth and sugarbeet were at the cotyledon stage, or two true-leaf sugarbeet stage and when Palmer amaranth was 7 cm tall. The selectivity indices for desmedipham, phenmedipham, and desmedipham + phenmedipham were 1.61, 2.47, and 3.05, respectively, at the cotyledon stage. At the two true-leaf application stage, the highest rates of desmedipham and phenmedipham were associated with low mortality rates in sugarbeet, resulting in a failed response of death. The highest rates of desmedipham + phenmedipham caused a death response of sugarbeet; the selectivity index was 2.15. Desmedipham treatments resulted in lower LD50 estimates for Palmer amaranth compared to phenmedipham, indicating that desmedipham can provide greater levels of control for Palmer amaranth. However, desmedipham also caused greater injury in sugarbeet, producing lower LD50 estimates compared to phenmedipham. Desmedipham + phenmedipham provided 90% or greater control of cotyledon-size Palmer amaranth at a labeled rate but also caused high levels of sugarbeet injury. Neither desmedipham, phenmedipham, nor desmedipham + phenmedipham was able to control 7-cm tall Palmer amaranth at previously labeled rates. Results indicate that desmedipham + phenmedipham can only control Palmer amaranth if applied at the cotyledon stage and a high level of sugarbeet injury is acceptable.


1990 ◽  
Vol 10 (12) ◽  
pp. 6700-6708
Author(s):  
L E Babiss ◽  
J M Friedman

We present evidence that differences in the levels of N-myc mRNA among different cell types are the result of posttranscriptional control. First, we noted that while steady-state mouse N-myc mRNA could be detected only in fetal mouse brain, it was transcribed at an equivalent rate in adult brain, liver, spleen, and placenta and in fetal brain. Similarly, the human N-myc gene was transcribed at an equivalent rate in HeLa cells, which do not accumulate this RNA in the cytoplasm, and cell lines G401 (a Wilms tumor-derived cell line) and SKNMc (established from a primitive neuroepithelioma), which do express N-myc RNA. As expected, the N-myc promoter functioned at equivalent rates, as demonstrated by the level of a reporter gene, when introduced into these cell types by using a recombinant adenovirus vector. The suggestion that posttranscriptional mechanisms control the level of this RNA was supported by the observation that sequences in the N-myc third exon specifically decreased the level of E1A mRNA when these sequences were placed downstream of the E1A promoter in a recombinant adenovirus. Finally, we further localized these sequences to a 600-bp fragment of the third exon by introducing various subclones of this sequence downstream of the E1A promoter in both viral and plasmid vectors.


2016 ◽  
Vol 3 (1) ◽  
Author(s):  
Kenta Sakaguchi ◽  
Makoto Hosono ◽  
Tomomi Imamura ◽  
Naomi Takahara ◽  
Misa Hayashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document